Document is current

Article History

Received: 28 September 2021

Accepted: 29 March 2022

First Online: 7 April 2022

Declarations

:

: IRB approval was obtained from the Olive View-UCLA Medical Center IRB prior to commencement of any research. Verbal, rather than written consent, was approved as the study obtained exemption status from the IRB due to the its minimal risk to subjects: the information contained in the interviews does not pertain to the subjects themselves and therefore was deemed minimal risk (no health information, no personal identifiers collected). Verbal consent was obtained via a standardized script approved by the IRB, and documented in a de-identified file where completed interviews were tracked. All interviews were audio-recorded after verbal consent was obtained.

: Not applicable.

: The authors declare that they have no competing interests. We have no financial relationships with the parties that manufacture or distribute naltrexone.